Jupiter Neurosciences (JUNS) Non-Current Assets (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Non-Current Assets of $739052.0 for Q4 2025, down 52.39% year-over-year from $1.6 million in Q4 2024, and down 21.7% quarter-over-quarter from $943901.0 in Q3 2025.
Jupiter Neurosciences (JUNS) Non-Current Assets (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Non-Current Assets for 3 consecutive years, with $739052.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Assets fell 52.39% year-over-year to $739052.0; the TTM figure through Dec 2025 stood at $4.2 million (changed N/A YoY), while the FY2025 annual figure was $739052.0, down 52.39% from the prior year.
- Non-Current Assets retreated to $739052.0 in Q4 2025 per JUNS's latest filing, from $943901.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.6 million in Q4 2024 and bottomed at $85032.0 in Q3 2024.
- Historically, Non-Current Assets has averaged $848636.1 across 3 years, with a median of $943901.0 in 2025.
- Annual changes were most pronounced in 2024 — Non-Current Assets jumped 1195.04% — and 2025, when it slumped 52.39%.
- Jupiter Neurosciences' Non-Current Assets stood at $119853.0 in 2023, then surged by 1195.04% to $1.6 million in 2024, then slumped by 52.39% to $739052.0 in 2025.
- Business Quant data shows JUNS's Non-Current Assets at $739052.0 in Q4 2025, $943901.0 in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 739,052.00 |
| Sep 30, 2025 | 943,901.00 |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 85,032.00 |
| Dec 31, 2023 | 119,853.00 |